FDA Inspection 1053161 — ABO Holdings Inc
The FDA completed an inspection of ABO Holdings Inc on April 26, 2018 in Cherry Hill, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cherry Hill, NJ (United States)